Kodiak Sciences Inc.
KOD- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001468748
No open-market purchases or sales by Kodiak Sciences Inc. insiders were filed in the last 90 days; 200 institutions reported holding it in 13F filings for Q2 2026, worth $2.36B in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Kodiak Sciences Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 96
- −5 vs. Q3 2023
- Shares held
- 41.0M
- −1.49M (−3.5%) vs. Q3 2023
- Total value
- $124.7M
- +$48.2M (+63.0%) vs. Q3 2023
- New holders
- 17
- 40 more added
- Sold out
- 22
- 19 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KOD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 200 | $2.36B |
| Q1 2026 | 188 | $2.21B |
| Q4 2025 | 158 | $1.61B |
| Q3 2025 | 121 | $727.8M |
| Q2 2025 | 101 | $155.7M |
| Q1 2025 | 107 | $120.3M |
| Q4 2024 | 108 | $418.7M |
| Q3 2024 | 98 | $103.0M |
| Q2 2024 | 106 | $94.3M |
| Q1 2024 | 114 | $228.0M |
| Q4 2023 | 96 | $124.7M |
| Q3 2023 | 101 | $76.5M |
| Q2 2023 | 128 | $293.6M |
| Q1 2023 | 127 | $254.8M |
| Q4 2022 | 136 | $298.2M |
| Q3 2022 | 143 | $324.6M |
| Q2 2022 | 131 | $313.1M |
| Q1 2022 | 142 | $330.5M |
| Q4 2021 | 153 | $3.82B |
| Q3 2021 | 153 | $4.37B |
| Q2 2021 | 149 | $4.18B |
| Q1 2021 | 167 | $5.02B |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Kodiak Sciences Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Algert Global LLC | 0 | $0 | 0.00% | −68,750−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −61,104−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −60,234−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −59,129−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −45,118−100.0% | Sold out |
| Capital Impact Advisors, LLC | 0 | $0 | 0.00% | −44,926−100.0% | Sold out |
| Parkwood LLC | 0 | $0 | 0.00% | −29,255−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −13,528−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −10,947−100.0% | Sold out |
| RIA Advisory Group LLC | 0 | $0 | 0.00% | −10,265−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −8,254−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −2,836−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −1,396−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −1,349−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −1,295−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −779−100.0% | Sold out |
| Newbridge Financial Services Group, Inc. | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −151−100.0% | Sold out |